TWO SIGMA SECURITIES, LLC - ADIAL PHARMACEUTICALS INC ownership

ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 21 filers reported holding ADIAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA SECURITIES, LLC ownership history of ADIAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$4,308
-74.8%
20,691
-57.6%
0.00%
Q1 2023$17,062
+152.9%
48,748
+55.3%
0.00%
Q4 2022$6,747
+12.4%
31,383
+76.3%
0.00%
Q3 2022$6,00017,8020.00%
Other shareholders
ADIAL PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
VANGUARD GROUP INC 282,909$424,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 4,223$6,0000.00%
VICTORY CAPITAL MANAGEMENT INC 1,470$2,0000.00%
BANK OF AMERICA CORP /DE/ 526$1,0000.00%
WELLS FARGO & COMPANY/MN 750$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 77,985$116,0000.00%
MORGAN STANLEY 535$1,0000.00%
BROWN ADVISORY INC 26,040$39,0000.00%
BlackRock Inc. 205,684$311,0000.00%
View complete list of ADIAL PHARMACEUTICALS INC shareholders